J Rheumatol
-
To study the prevalence of joint hypermobility and the association of hypermobility with musculoskeletal pain in pre-adolescents. ⋯ Both joint hypermobility and musculoskeletal pain are common in pre-adolescents. Hypermobility appears not to be a contributing factor to musculoskeletal pain in pre-adolescents.
-
To evaluate the validity and reliability of recordings of pain location among patients with pain from 2 different sources, using the McGill Pain Map (MPM). ⋯ Recordings of pain location using the MPM are valid and reliable. The MPM is a valuable instrument for studies of the distribution of pain in populations.
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
To compare the efficacy and tolerability of lornoxicam and diclofenac in the treatment of patients with osteoarthritis (OA) over 12 weeks and to assess the efficacy and tolerability of lornoxicam over a followup period of 40 weeks. ⋯ Lornoxicam 4 mg tid and 8 mg bid were as effective as diclofenac 50 mg tid for the treatment of OA. There was no significant difference in tolerability of these regimens. Thus, lornoxicam appears to be a useful therapeutic alternative to diclofenac in patients with OA.
-
To evaluate the predictors of improvement at 2 years in subjects with chronic widespread pain ascertained from a community survey. ⋯ Chronic widespread pain in the community has a generally good prognosis. However, those with additional symptoms associated with the fibromyalgia syndrome were more likely still to have chronic widespread pain 2 years later.